Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Karla Santos-de-Frutos and Nabil Djouder in the lab. Image coutesy of Antonio Tabernero. CNIO
News | Radiation Therapy
Discovered Key Mechanisms to Improve Intestinal Regeneration and Alleviate the Side Effects of Radiotherapy

September 15, 2022 — The intestine is very susceptible and is affected by the harsh conditions caused by DNA-altering ...

Time September 15, 2022
arrow
RaySearch Laboratories AB (publ) announces that Sunnybrook Health Sciences Centre – Odette Cancer Centre in Toronto, Canada, has placed an order for RayStation treatment planning system.
News | Treatment Planning
Sunnybrook Health Sciences Centre in Canada selects RayStation

September 12, 2022 — Sunnybrook Health Sciences Centre, one of Canada’s largest hospitals, offers a highly specialized ...

Time September 12, 2022
arrow
Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing 18F-DCFPyl PSMA PET/CT staging. Image created by M.Ng et al, GenesisCare, Melbourne, Australia.
News | Prostate Cancer
New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50% of Prostate Cancer Patients

September 8, 2022 — In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with ...

Time September 08, 2022
arrow
Accuray Will Anchor Hub That Will Unite Companies From the MedTech, Pharma and Biosciences Sectors, Physicians and Scientists
News | Radiology Business
Accuray Partners with Swiss-based Genolier Innovation Hub to Bring Medical and Technological Advances to Patients Faster

September 7, 2022 — Accuray Incorporated announced the company is joining forces with Genolier Innovation Hub, a fully ...

Time September 07, 2022
arrow
A key milestone and partnership for the clinical implementation of upright radiotherapy has been announced. RaySearch Laboratories AB (publ) and Leo Cancer Care in Horley, Great Britain, are joining forces to offer a streamlined treatment planning solution for upright treatments
News | Radiation Therapy
RaySearch and Leo Cancer Care Join Forces to Enable Upright Radiotherapy

September 2, 2022 — A key milestone and partnership for the clinical implementation of upright radiotherapy has been ...

Time September 02, 2022
arrow
The first of 396 patients has been enrolled into the PROTECT-trial with the aim of setting new standards for the clinical use of proton radiotherapy in esophageal cancer
News | Proton Therapy
The PROTECT-Trial Consortium Enrolls First Patient into Proton Therapy Study

September 2, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, today ...

Time September 02, 2022
arrow
By combining the portfolios of both companies, IBA Dosimetry and ScandiDos can accomplish this vision, offering an increasingly extensive suite of products that provide a consistent solution for all aspects of radiotherapy quality assurance.
News | Radiation Therapy
IBA and ScandiDos Form Strategic Alliance to Increase Access to Safe Radiotherapy

September 1, 2022 — IBA S.A., a leader in particle accelerator technology and a leader in dosimetry quality assurance ...

Time September 01, 2022
arrow
ASTRO’s first guideline for lower-grade glioma outlines best practices for patient-centered, multidisciplinary care
News | Radiation Therapy
ASTRO Issues Clinical Guideline on Radiation Therapy for IDH-Mutant Glioma

August 31, 2022 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time August 31, 2022
arrow
Three machine deal expands potential of biology-guided radiotherapy to Pacific Northwest
News | PET Imaging
RefleXion Announces Multi System Contract with Select Healthcare

August 30, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT), a ...

Time August 30, 2022
arrow
News | Radiopharmaceuticals and Tracers
NorthStar Medical Radioisotopes Announces Supply Agreement with Aktis Oncology, Inc. for Alpha-Emitting Therapeutic Radioisotope Actinium-225 (Ac-225)

August 26, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time August 25, 2022
arrow
Dr. Monowar Aziz (left), Dr. Ping Wang (middle) and Dr. Max Brenner (right) recently received a $3.8 million grant to study sepsis and radiation. (Credit: Northwell Health)
News | Radiation Therapy
NIH awards Feinstein Institutes $3.8M to Study Radiation Exposure and Sepsis

August 24, 2022 — Terrorism, acts of war, nuclear power plant malfunctions; the risk of massive radiation exposure is ...

Time August 24, 2022
arrow
This agreement brings together the complementary research and development expertise of both institutions to advance innovative intellectual property from MD Anderson to improve the delivery of radiation therapy for patients with cancer
News | Radiation Therapy
MD Anderson and Empyrean Announce Agreement to Develop Novel Radiation Therapy Technologies

August 24, 2022 — The University of Texas MD Anderson Cancer Center and Empyrean Medical Systems, Inc. today announced ...

Time August 24, 2022
arrow
Elekta announced that it has received CE mark for its Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform.
News | Radiation Therapy
Elekta’s New Radiosurgery System, Elekta Esprit, Receives CE Mark

August 23, 2022 — Elekta announced that it has received CE mark for its Elekta Esprit, a new Leksell Gamma Knife ...

Time August 23, 2022
arrow
Ms Preetha Reddy (Executive Vice Chairman AHEL), Dr Prathap Reddy (Chairman AHEL), Olivier Legrain (CEO IBA) & Dr Rakesh Jalali (Clinical Director APCC)
News | Proton Therapy
IBA and Apollo Proton Cancer Centre Sign a Collaboration Agreement to Provide Proton Therapy Training and Education Programs in Asia

August 19, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time August 19, 2022
arrow
Recently published research out of VCU Massey Cancer Center demonstrated that cancer patients who live in rural areas experience higher mortality rates than nonrural cancer patients, among those receiving radiation treatment
News | Radiation Therapy
Rural Cancer Patients Undergo Less Radiation Treatment and Experience Poorer Outcomes

August 19, 2022 — Recently published research out of VCU Massey Cancer Center demonstrated that cancer patients who live ...

Time August 19, 2022
arrow
A new study published by University of Kentucky Markey Cancer Center researchers suggests that the common steroid betamethasone could be used to reduce unwanted side effects of radiation treatments for prostate cancer.
News | Prostate Cancer
Betamethasone Could Improve Outcomes for Prostate Cancer Radiation Therapy

August 16, 2022 — A new study published by University of Kentucky Markey Cancer Center researchers suggests that the ...

Time August 16, 2022
arrow
With Brainlab ExacTrac Dynamic® Deep Inspiration Breath Hold module, clinicians are able to correlate internal and external anatomy, revealing any misalignment that may otherwise remain undetected. (Source: Brainlab)
News | Breast Imaging
Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities

August 15, 2022 — Brainlab announced the first group of breast cancer patients treated in United States with the ...

Time August 15, 2022
arrow
Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News | Lung Imaging
Mount Sinai Awarded Three-Year Grant to Explore Therapeutic Approaches to KRAS Mutant Lung Tumors

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

Time August 10, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News | Breast Imaging
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News | Lung Imaging
IASLC Early Detection and Screening Committee to Report on Global Obstacles to Lung Cancer Screening

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now